DOI: https://doi.org/10.18370/2309-4117.2018.42.76-81

Features of the somatic status and clinical characteristics of breast cancer in postmenopausal women

С. М. Грибач

Abstract


Breast cancer (BC) is one of the most urgent as medical and social problems. In Ukraine, from 1995 to the present time, BC occupies the first rank in the structure of cancer morbidity and mortality among women. In the analysis of the incidence of BC, there are two age spikes: the first peak is 40–45 years (premenopausal BC), the second – after 50–65 years (postmenopausal BC). Features of the tumor process in postmenopausal women can be modified by a number of somatic diseases (obesity of varying degrees, vascular diseases, diseases of the gastrointestinal tract, etc.).

129 patients in postmenopausal women who were diagnosed with stage I–III breast cancer were examined. Analysis of clinical data showed a different prevalence of the tumor process in the mammary glands of patients. The greatest number of patients with stage II of BC (80 patients, 62.0%), in other patients the prevalence of the tumor process corresponded to stage I (16 people, 12.4%) and stage III of BC (33 patients, 25.6%). Based on the survey, most postmenopausal patients with BC have signs of metabolic status disorders, namely high body mass index, obesity of grade II–III, a wide range of gynecological and somatic diseases carried over the course of their life. The size of breast tumors was variable and ranged from 1cm to 2.5cm or more, which is respectively observed in 34.9% and 56.6% of observations. The total number of patients with different degrees of regional lymph node metastases was 76%, but the advantage of fewer affected lymph nodes was noted. The heterogeneity of tumors with histological variants with prevalence of infiltrative protocol cancer was established (51.9% of patients).

The obtained results testify to the necessity of an integrated approach to the examination of patients with postmenopausal pulmonary arterial hypertension, including the somatic status and metabolic syndrome, which can modify the features of the course of the tumor process.


Keywords


breast cancer; postmenopausal; body mass index; clinical features; concomitant pathology

References


Siegel, R.L., Miller, K.D., Jemal, A. “Cancer statistics.” Cancer J Clin 66 (2016): 7–30.

Bulletin of the National Cancer Register of Ukraine No. 18. Kyiv (2017). Available from: [http://www.ncru.inf.ua/publications/BULL_18/index. htm], last accessed Aug 22, 2018.

Imianitov, E.N., Hanson, K.P. Molecular oncology: clinical aspects. St. Petersburg. SPbMAPO Publishing House (2007): 212 p.

Berstein, L.M. “Diabetes, obesity and oncological morbidity: risks and anti-risks.” Diabetes mellitus 4 (2012): 81–2.

Zadav, N.K., Poudel, B., Thanpari, C., Koner, B.C. “Assessment of biochemical profiles in premenopausal and postmenopausal women with breast cancer.” Asian Рacific J Cancer Prev 13 (2012): 3385–8.

Yanquez, F.J., Clements, J.M., Grauf, D., Merchant, A.M. “Synergistic effect of age and body mass index on mortality and morbidity in general surgery.” J Surg Res 184 (2013): 89–100.

Puts, M.T., Tu, H.A., Tourangeau, A., еt al. “Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review.” Ann Oncol 25 (2014): 564–77.

Zagaiko, A.L., Lytkin, D.V. “Pharmacological value of aromatase inhibitors.” Ukrainian biopharmaceutical journal 5.46 (2016): 70–3.

Lykholat, T.J., Lykholat, O.A., Nedzvetsskyi, V.S., Laktionov, V.V. “Alimentary triggers of hormone-dependent forms of breast cancer.” Bulletin of the DNU. Seryes: Biology, Ecology 22.1 (2014): 33–7.

Tarutinov, V.I. Breast: cancer and precancerous diseases. Kyiv. Naukova dumka (2009): 480 p.

Karn, T., Pusztai, L., Rody, A., et al. “The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Biomarkers.” Curr Cancer Drug Targets 15.8 (2015): 652–64.

Lyubchenko, L.N., Bateneva, Y.I., Vorotnikov, I.K., et al. “Hereditary breast cancer: genetic and clinical heterogeneity, molecular diagnostics, surgical prophylaxis in at-risk groups.” Adv Mol Oncol 1 (2014): 16–25.

Yue, W., Santen, R.J., Wang, J.P., et al. “Genotoxic metabolites of estradiol in breast: potentiall mechanism of estradiol induced carcinogenesis.” J Steroid Biochem Mol Biol 86.5 (2003): 477–86.

Lopez Sanchez, M.I., Shearwood, A.M., Chia, T., et al. “Estrogen-mediated regulation of mitochondrial gene expression.” Mol Endocrinol 29.1 (2015): 14–27.

Henderson, B.E., Feigelson, H.S. “Hormonal carcinogenesis.” Carcinogenesis 21.3 (2000): 427–33.

Bergen, E.S., Tichy, C., Berghoff, A.S., et al. “Prognostic impact of breast cancer subtypes in elderly patients.” Breast Cancer Res Treat 157 (2016): 91–9.

De Kruijf, E.M., Bastiaannet, E., Rubertà, F., еt al. “Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.” Mol Oncol 8.5 (2014): 1014–25.

Montroni, I., Rocchi, M., Santini, D., еt al. “Has breast cancer in the elderly remained the same over recent decades? A comparison of two groups of patients 70 years or older treated for breast cancer twenty years apart.” J Geriatr Oncol 5.3 (2014): 260–5.

Bershtein, L.M., Dilman, V.M. “Prognosis in patients with breast cancer, in the anamnesis of which the birth of a large fetus.” Questions of oncology 27.6 (1984): 54–8.

Caan, B.J., Kwan, M.L., Hartzell, G., et al. “Pre-diagnosis body mass index, post-diagnosis weight change and prognosis among women with early stage breast cancer.” Cancer Causes Contr 19 (2008): 1319–28.

Keum, N., Greenwood, D.C., Lee, D.H., еt al. “Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.” J Natl Cancer Inst 107.2 (2015): 356–67.

Dzgoeva, D.H. “Obesity and dyslipidemia.” In: Obesity. Metabolic syndrome. Diabetes mellitus type 2. Ed. by I.I. Dedova. Moscow (2000): 14–8.


GOST Style Citations


1.       Siegel, R.L., Miller, K.D., Jemal, A. “Cancer statistics.” Cancer J Clin 66 (2016): 7–30.

2.       Бюлетень Національного канцер-реєстру України № 18. Київ, 2017.

3.       Имянитов, Е.Н., Хансон, К.П. Молекулярная онкология: клинические аспекты. – Санкт-Петербург: ИД СПбМАПО, 2007. – 212 с.

4.       Берштейн, Л.М. Диабет, ожирение и онкологическая заболеваемость: риски и антириски / Л.М. Берштейн // Diabetes mellitus. – 2012. – № 4. – С. 81–82.

5.       Zadav, N.K., Poudel, B., Thanpari, C., Koner, B.C. “Assessment of biochemical profiles in premenopausal and postmenopausal women with breast cancer.” Asian Рacific J Cancer Prev 13 (2012): 3385–8.

6.       Yanquez, F.J., Clements, J.M., Grauf, D., Merchant, A.M. “Synergistic effect of age and body mass index on mortality and morbidity in general surgery.” J Surg Res 184 (2013): 89–100.

7.       Puts, M.T., Tu, H.A., Tourangeau, A., еt al. “Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review.” Ann Oncol 25 (2014): 564–77.

8.       Загайко, А.Л. Фармакологічне значення інгібіторів ароматази / А.Л. Загайко, Д.В. Литкiн // Український біофармацевтичний журнал. – 2016. – № 5(46). – С. 70–73.

9.       Лихолат, Т.Ю. Аліментарні тригери гормонозалежних форм раку молочної залози / Т.Ю. Лихолат, О.А. Лихолат, В.С. Недзвецький, В.В. Лактіонов // Вісник ДНУ. Сер.: Біологія, екологія. – 2014. – № 22(1). – С. 33–37.

10.     Тарутинов, В.И. Молочная железа: рак и предраковые заболевания. – Київ: Наукова думка, 2009. – 480 с.

11.     Karn, T., Pusztai, L., Rody, A., et al. “The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Biomarkers.” Curr Cancer Drug Targets 15.8 (2015): 652–64.

12.     Lyubchenko, L.N., Bateneva, Y.I., Vorotnikov, I.K., et al. “Hereditary breast cancer: genetic and clinical heterogeneity, molecular diagnostics, surgical prophylaxis in at-risk groups.” Adv Mol Oncol 1 (2014): 16–25.

13.     Yue, W., Santen, R.J., Wang, J.P., et al. “Genotoxic metabolites of estradiol in breast: potentiall mechanism of estradiol induced carcinogenesis.” J Steroid Biochem Mol Biol 86.5 (2003): 477–86.

14.     Lopez Sanchez, M.I., Shearwood, A.M., Chia, T., et al. “Estrogen-mediated regulation of mitochondrial gene expression.” Mol Endocrinol 29.1 (2015): 14–27.

15.     Henderson, B.E., Feigelson, H.S. “Hormonal carcinogenesis.” Carcinogenesis 21.3 (2000): 427–33.

16.     Bergen, E.S., Tichy, C., Berghoff, A.S., et al. “Prognostic impact of breast cancer subtypes in elderly patients.” Breast Cancer Res Treat 157 (2016): 91–9.

17.     De Kruijf, E.M., Bastiaannet, E., Rubertà, F., еt al. “Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.” Mol Oncol 8.5 (2014): 1014–25.

18.     Montroni, I., Rocchi, M., Santini, D., еt al. “Has breast cancer in the elderly remained the same over recent decades? A comparison of two groups of patients 70 years or older treated for breast cancer twenty years apart.” J Geriatr Oncol 5.3 (2014): 260–5.

19.     Берштейн, Л.М. Прогноз у больных раком молочной железы, в анамнезе которых роды крупным плодом / Л.М. Берштейн, В.М. Дильман // Вопросы онкологии. – 1984. – № 27(6). – С. 54–58.

20.     Caan, B.J., Kwan, M.L., Hartzell, G., et al. “Pre-diagnosis body mass index, post-diagnosis weight change and prognosis among women with early stage breast cancer.” Cancer Causes Contr 19 (2008): 1319–28.

21.     Keum, N., Greenwood, D.C., Lee, D.H., еt al. “Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.” J Natl Cancer Inst 107.2 (2015): 356–67.

22.     Дзгоева, Д.Х. Ожирение и дислипидемия / Д.Х. Дзгоева // Ожирение. Метаболический синдром. Сахарный диабет 2 типа / Под ред. И.И. Дедовой. – М.: 2000. – С. 14–18.





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)